Pfizer Chairman and CEO Albert Bourla said in a public statement Friday that the company won't have data showing that the vaccine is safe before the third week of November at the earliest.
If the company's vaccine candidate pans out, Americans can receive it for free under the deal. The arrangement is part of the U.S. government's push to have a vaccine widely available by January.
The pharmaceutical giant said it would be abandoning its neuroscience development programs and allocating its spending elsewhere. The move also means the company will lay off some 300 employees.
A county judge and the state supreme court ordered the state not to put the inmates to death. The larger case challenges lethal drugs. The other argues that the inmate is not sane.
The medication is the only one available to prevent an infected pregnant woman from passing the disease to a fetus. Pfizer says the shortage should be over in July.
The drugmaker was the "last remaining open-market source of drugs used in executions," The New York Times reported. Other U.S. and European firms had already blocked drugs from use in executions.
President Obama calls the controversial practice "one of the most insidious tax loopholes out there." Now the Treasury Department has introduced rules aimed at reducing the incentives for inversions.
